Valeo Financial Advisors’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Valeo Financial Advisors’s Portfolio NVIV Stock Details NVIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Hold	0	–	–	–	2115
2021 Q1	–	Hold	0	–	–	–	2271
2020 Q4	–	Hold	0	–	–	–	1941
2020 Q3	–	Hold	0	–	–	–	2304
2020 Q2	–	Hold	0	–	–	–	2228
2020 Q1	–	Hold	0	–	–	–	1996
2019 Q4	–	Sell	-1	Closed	-$249	–	1787
2019 Q3	$0	Hold	1	–	–	﹤0.01%	1742
2019 Q2	$0	Hold	1	–	–	﹤0.01%	1726
2019 Q1	$1K	Hold	1	–	–	﹤0.01%	1533
2018 Q4	$1K	Hold	1	–	–	﹤0.01%	1456
2018 Q3	$1K	Buy	+1	New	+$1.47K	﹤0.01%	1756
2018 Q2	–	Hold	0	–	–	–	1834
2018 Q1	–	Hold	0	–	–	–	1296
2017 Q4	–	Hold	0	–	–	–	1096

Other funds holding NVIV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Valeo Financial Advisors's NVIV Position: Q2 2021 in Review

Valeo Financial Advisors held its InVivo Therapeutics Holdings Corp (NVIV) position steady in Q2 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2115.

Valeo Financial Advisors first reported a position in NVIV in Q3 2018 and has held it in 5 quarters since. The position peaked at $1K in Q1 2019. 19 funds tracked by Wall St. Rank hold NVIV as of Q2 2021.

Valeo Financial Advisors held 0 shares of InVivo Therapeutics Holdings Corp worth $0 as of Q2 2021.
Valeo Financial Advisors left its InVivo Therapeutics Holdings Corp share count unchanged in Q2 2021.
InVivo Therapeutics Holdings Corp made up ﹤0.01% of Valeo Financial Advisors's portfolio in Q2 2021, its #2115 holding.
Valeo Financial Advisors first reported a position in InVivo Therapeutics Holdings Corp in Q3 2018 and has held it in 5 quarters since.
Valeo Financial Advisors's InVivo Therapeutics Holdings Corp position peaked at $1K in Q1 2019.
19 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.